Question 1

What specific information can the MSDX Complex-1 test provide about my treatment response?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

Question 2

How will participating in this study affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with the biomarker testing?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I decide to stop participating in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my privacy be protected during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

Question 6

What are the next steps if the biomarker test shows a change in my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis clinical trial (NCT01541618). Contact the study team or your healthcare provider for specific answers.

What this study is about